申请人:Neubig Richard
公开号:US20120277273A1
公开(公告)日:2012-11-01
The invention relates to compositions having RGS (regulator of G-protein Signaling) inhibiting activity, and methods of use thereof. In some embodiments, RGS-inhibiting compositions find use in research on or treatment of disease states (e.g., diabetes, epilepsy, neuropathic pain, depression and other diseases).
该发明涉及具有RGS(G蛋白信号调节因子)抑制活性的组合物,以及其使用方法。在某些实施例中,具有RGS抑制活性的组合物可用于研究或治疗疾病状态(例如糖尿病、癫痫、神经痛、抑郁症和其他疾病)。